Cargando…
Development and Comparison of Warfarin Dosing Algorithms in Stroke Patients
PURPOSE: The genes for cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase complex subunit 1 (VKORC1) have been identified as important genetic determinants of warfarin dosing and have been studied. We developed warfarin algorithm for Korean patients with stroke and compared the accuracy of...
Autores principales: | Cho, Sun-Mi, Lee, Kyung-Yul, Choi, Jong Rak, Lee, Kyung-A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Yonsei University College of Medicine
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4800352/ https://www.ncbi.nlm.nih.gov/pubmed/26996562 http://dx.doi.org/10.3349/ymj.2016.57.3.635 |
Ejemplares similares
-
Development and Validation of a Novel Warfarin Dosing Algorithm for Korean Patients With VKORC1 1173C
por: Cho, Eun Hye, et al.
Publicado: (2020) -
VKORC1 and CYP2C9 Genotype Variations in Relation to Warfarin Dosing in Korean Stroke Patients
por: Park, Sea Mi, et al.
Publicado: (2013) -
Validation and comparison between two warfarin dosing clinical algorithms and warfarin fixed dosing in specialized heart center: cross-sectional study
por: Elnour, Asim Ahmed, et al.
Publicado: (2022) -
Genotype-guided warfarin dosing may benefit patients with mechanical aortic valve replacements: randomized controlled study
por: Lee, Kyung Eun, et al.
Publicado: (2020) -
Comparison of Enoxaparin and Warfarin for Secondary Prevention of Cancer-Associated Stroke
por: Jang, Hyemin, et al.
Publicado: (2015)